LadRx Corporation Announces OTCQB Ticker Change to LADX

LOS ANGELES–(BUSINESS WIRE)–LadRx Corporation (OTCQB: LADX) (“LadRx” or the “Company”), a biopharmaceutical innovator focused on research and development of life-saving cancer therapeutics, today announced it is changing its OTCQB ticker symbol from CYTR to LADX effective Thursday, October 6, 2022. Chief Executive Officer Stephen Snowdy, PhD commented, “Following up on…